124 related articles for article (PubMed ID: 7599368)
1. Medroxyprogesterone treatment for paraphiliacs.
Kravitz HM; Haywood TW; Kelly J; Wahlstrom C; Liles S; Cavanaugh JL
Bull Am Acad Psychiatry Law; 1995; 23(1):19-33. PubMed ID: 7599368
[TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone and paraphiles: do testosterone levels matter?
Kravitz HM; Haywood TW; Kelly J; Liles S; Cavanaugh JL
Bull Am Acad Psychiatry Law; 1996; 24(1):73-83. PubMed ID: 8891323
[TBL] [Abstract][Full Text] [Related]
3. Depo provera treatment for sex offending behavior: an evaluation of outcome.
Meyer WJ; Cole C; Emory E
Bull Am Acad Psychiatry Law; 1992; 20(3):249-59. PubMed ID: 1421556
[TBL] [Abstract][Full Text] [Related]
4. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias.
Gottesman HG; Schubert DS
J Clin Psychiatry; 1993 May; 54(5):182-8. PubMed ID: 8509348
[TBL] [Abstract][Full Text] [Related]
5. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
Harel Z; Biro FM; Kollar LM
J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of paraphilic and nonparaphilic sexual disorders.
Guay DR
Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
[TBL] [Abstract][Full Text] [Related]
7. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
Saleh FM; Berlin FS
J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
[TBL] [Abstract][Full Text] [Related]
8. Treatment of sex offenders with Depo-Provera.
Kiersch TA
Bull Am Acad Psychiatry Law; 1990; 18(2):179-87. PubMed ID: 2142608
[TBL] [Abstract][Full Text] [Related]
9. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
Kafka MP; Prentky R
J Clin Psychiatry; 1992 Oct; 53(10):351-8. PubMed ID: 1429474
[TBL] [Abstract][Full Text] [Related]
11. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
12. Use of depo-provera in the treatment of aggressive sexual offenders: preliminary report of three cases.
Barry DJ; Ciccone JR
Bull Am Acad Psychiatry Law; 1975; 3(3):179-84. PubMed ID: 1230194
[TBL] [Abstract][Full Text] [Related]
13. Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series.
Saleh FM; Niel T; Fishman MJ
J Forensic Sci; 2004 Nov; 49(6):1343-8. PubMed ID: 15568711
[TBL] [Abstract][Full Text] [Related]
14. The paraphilias and Depo-Provera: some medical, ethical and legal considerations.
Berlin FS
Bull Am Acad Psychiatry Law; 1989; 17(3):233-9. PubMed ID: 2529006
[TBL] [Abstract][Full Text] [Related]
15. Policing "perversions": Depo-Provera and John Money's new sexual order.
Tsang DC
J Homosex; 1995; 28(3-4):397-426. PubMed ID: 7560938
[TBL] [Abstract][Full Text] [Related]
16. Sexual fantasies of adolescent male sex offenders in residential treatment: a descriptive study.
Aylwin AS; Reddon JR; Burke AR
Arch Sex Behav; 2005 Apr; 34(2):231-9. PubMed ID: 15803256
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacological therapy of deviant sexual behavior.
Murray JB
J Gen Psychol; 1988 Jan; 115(1):101-10. PubMed ID: 2965214
[TBL] [Abstract][Full Text] [Related]
18. Cholelithiasis associated with medroxyprogesterone acetate therapy in men.
Meyer WJ; Wiener I; Emory LE; Cole CM; Isenberg N; Fagan CJ; Thompson JC
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):69-84. PubMed ID: 1385654
[TBL] [Abstract][Full Text] [Related]
19. Multiple paraphilic diagnoses among sex offenders.
Abel GG; Becker JV; Cunningham-Rathner J; Mittelman M; Rouleau JL
Bull Am Acad Psychiatry Law; 1988; 16(2):153-68. PubMed ID: 3395701
[TBL] [Abstract][Full Text] [Related]
20. [Clinical pharmacokinetics and practical consequences of optimal use of medroxyprogesterone acetate].
Etienne MC; Milano G; Namer M
Bull Cancer; 1993 May; 80(5):431-8. PubMed ID: 8173196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
